Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 279-506-0 | CAS number: 80584-92-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 24,2012 - August 14,2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes
- Remarks:
- hameln rds a.s., Section of Biological Studies, Hormi 36, 900 01 Modra, Slovak Republic, Department of Microbiology
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid
- EC Number:
- 279-505-5
- EC Name:
- 6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid
- Cas Number:
- 80584-91-4
- Molecular formula:
- C21H36N6O6
- IUPAC Name:
- 6,6',6''-(1,3,5-triazine-2,4,6-triyltriimino)trihexanoic acid
- Details on test material:
- - Physical state: White powder
- Storage condition of test material: Ambient temperature (15- 25°C)
Constituent 1
Method
- Target gene:
- hprt
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Dulbecco's Modified Eagle's medium (DMEM) with 4.5 g/L of glucose supplemented with L-glutamine, Penicillin, Streptomycin and 10 % FBS (growth medium only)
- Properly maintained: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- post-mitochondrial fraction (S-9) prepared from 20-methylcholanthrene induced Sprague-Dawley rats.
- Test concentrations with justification for top dose:
- Range finder: 0; 0.75; 7.5; 15; 30; 60; 120; 240; 480 µg/ml
Main experiment I: 0; 3.75; 7.5; 15; 30; 60; 120 µg/ml (-S9); 0; 7.5; 15; 30; 60; 120; 240; 480 µg/ml (+S9)
Main experiment II: 0; 7.5; 15; 30; 60; 120; 240; 480 µg/ml (+S9 and -S9) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO;
- Justification for choice of solvent/vehicle: solubility considerations
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- with and without S9
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with and without S9
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Remarks:
- DMBA: 3 µg/ml with S9; EMS: 600 µg/ml without S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 3 hours with and without S9-mix
- Expression time (cells in growth medium): 7 days
- Selection time (if incubation with a selection agent): 7 days
- Fixation time (start of exposure up to fixation or harvest of cells): 14 days
SELECTION AGENT (mutation assays): 10 µg/mL of 6TG
NUMBER OF REPLICATIONS: single cultures
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency - Evaluation criteria:
- For valid data, the test article was considered to induce forward mutation at the hprt locus in Chinese hamster lung V79 cells if:
1. The mutant frequency at one or more concentrations was at least 3-fold greater than that of the negative control
2. Concentration-related increase in mutant frequency
3. The effects described above were reproducible. - Statistics:
- Multiple sample comparison of treated and untreated cell sets was processed applying Kruskal-Wallis test. The P-value from the test was considered to draw the relevant conclusion about statistical significance. Significance level of p<0.01 was taken into account. Multiple sample comparison was followed by two sample test applying Mann-Whitney W test to compare the medians of the two samples. The difference between medians was considered statistically significant at p<0.01. All individual values of frequencies are presented together with summary statistics involving count, average, standard deviation, coefficient of variation, minimum, maximum, range and standard skewness.
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No marked changes of pH of treatment media were observed in the Range-Finder experiments at concentrations up to 480 µg/mL tested as compared to the concurrent vehicle controls.
- Effects of osmolality: The osmolality values were within the physiological ranges for these cells.
- Precipitation: No precipitate was observed in any experiment upon addition of the test article to the cultures or at the end of the 3 hour incubation period.
RANGE-FINDING/SCREENING STUDIES:
In the initial cytotoxicity Range-Finder experiment up to eight concentrations were tested in the absence of S-9 ranging from 0.75 to 480 µg/mL. At these concentrations, reductions in RPE values (%RPE reduced to 10 to 20%) were not achieved. Based on these results, the concentrations ranging from 3.75 µg/mL to 480 µg/mL were chosen for in vitro mammalian cell gene mutation tests in the absence and the presence of S-9.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
There was no indication for induced cytotoxicity in the absence and presence of S-9. In experiment I, the highest concentration plated for viability assessment (%RPE) was 120 µg/mL in the absence of S-9 and 480 µg/mL in the presence of S-9, which gave ~115.2% and ~72.6% RPE, respectively. In experiment II, the highest concentration plated for viability assessment (RPE) was 480 µg/mL in the absence and presence of S-9, which gave ~102% and ~82.6% RPE, respectively. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Experimental Result
Experiment I, 3h treatment | Treatment (µg/mL) |
S9 mix | %RPE | MFa |
Vehicle | - | 100 | 10.8 | |
3.75 | - | 121 | 10.3 | |
7.5 | - | 116.8 | 8.9 | |
15 | - | 115.3 | 15.1 | |
30 | - | 117.1 | 30.7* | |
30 | - | 110.7 | 19.8 | |
120 | - | 115.2 | 10.1 | |
EMS (600) | - | 120.5 | 166.7* | |
Vehicle | + | 100 | 6.3 | |
7.5 | + | 84.9 | 5.3 | |
15 | + | 100 | 1 | |
30 | + | 96.5 | 3.9 | |
30 | + | 80.5 | 5.3 | |
120 | + | 91.1 | 16.1* | |
240 | + | 95.6 | 17.9 | |
480 | + | 72.6 | 4.9 | |
DMBA (3) | + | 79.6 | 123.9* | |
Experiment II, 3h treatment | Vehicle | - | 100 | 17 |
7.5 | - | 107.4 | 6.5 | |
15 | - | 106.6 | 9.5 | |
30 | - | 116.5 | 21.4 | |
30 | - | 88 | 31.6 | |
120 | - | 108.3 | 9.4 | |
240 | - | 98.7 | 14.1 | |
480 | - | 102 | 12.5 | |
EMS (600) | - | 94.7 | 227.6* | |
Vehicle | + | 100 | 19.5 | |
7.5 | + | 100.8 | 31.5 | |
15 | + | 107.2 | 9.6 | |
30 | + | 110.3 | 7.3 | |
30 | + | 103.6 | 17.8 | |
120 | + | 98.4 | 39.7* | |
240 | + | 98.8 | 5.9 | |
480 | + | 82.6 | 10.7 | |
DMBA (3) | + | 67.6 | 327.8* |
a 6TG-resistant mutants/106 viable cells 7 days after treatment
* statistically (p < 0.01) significant using the Kruskal-Wallis test
Applicant's summary and conclusion
- Conclusions:
- It is concluded that the test substance did not induce mutation at the hprt locus of V79 Chinese Hamster lung cells when tested under the conditions employed in this study.
- Executive summary:
In a GLP-compliant OECD 476 study the test substance was assayed for the ability to induce mutation at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus in Chinese hamster lung V79 cells. The study consisted of a cytotoxicity Range-Finder experiment followed by two main mutation experiments, each conducted in the absence and presence of metabolic activation by 20-methylcholanthrene induced rat liver post-mitochondrial fraction (S-9). The test item was formulated in DMSO and dosed at 1% v/v. A 3 hour treatment incubation period was used for all experiments. The highest concentration tested which gave acceptable survival (measured by relative plating efficiency [RPE]) was 480 µg/mL (limit of solubility) in the absence of S-9, which gave ~110.4% RPE. Accordingly, for Experiment 1 six or seven concentrations ranging from 3.75 to 480 µg/mL were tested both in the absence and presence of S-9. Seven days after treatment, the highest concentration selected to determine viability and 6TG resistance was 120 µg/mL in the absence of S-9 and 480 µg/mL in the presence of S-9, which gave ~ 115.2 % and 72.6% RPE, respectively. In Experiment 2 the test article was tested in conc. range of 7.5 - 480 µg/mL both in the absence and presence of S-9. Seven days after treatment the highest concentration selected to determine viability and 6TG resistance was 480 µg/mL both in the absence and presence of S-9, which gave ~ 102% and ~ 82.6% RPE, respectively. Negative (vehicle) and positive control treatments were included in each Mutation Experiment in the absence and presence of S-9. Mutant frequencies in negative control were consistent with the acceptable range and clear increases in mutant frequency were observed by the positive controls. The assay system was therefore considered to be both sensitive and valid.
In Experiment 1 in the absence of S-9 statistically significant increase in mean mutant frequency (MMF) was only observed at concentration of 30 µg/mL. At this level RPE was not reduced (RPE ~ 117.1% ). The increase in MMF was not greater than 3-fold above that of the concurrent vehicle control and this effect was not reproduced in independent Experiment 2. In the presence of S-9, statistically significant increase in mean mutant frequency was observed at concentration of 120 µg/mL only. Fold increases greater than 3-fold over the vehicle control was not observed and mutant frequency fall within the range of historical control (for solvent DMSO). Cytotoxicity (expressed in terms of %RPE at the end of treatment) was ~ 91.1 %.
In experiment 2 in the absence of S-9, exposure to concentrations up to 480 µg/mL for 3h resulted in a negative response. Cytotoxic effects of test item were not observed in the whole concentration range of 7.5 - 480 µg/mL. In the presence of S-9 statistically significant increase in mean mutant frequency was found at concentration of 120 µg/mL only. At this concentration the increase in MMF was not greater than 3-fold above that of the concurrent vehicle control. There was no indication for induced cytotoxicity. No evidence of an increase in MMF was observed at any of the other concentrations tested.
It is concluded that the test substance did not induce mutation at the hprt locus of V79 Chinese Hamster lung cells when tested under the conditions employed in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.